For a drug like Lipitor, it took about 6 to 7 years in clinical research before it was approved by the FDA so it really got about a 14 year patent life," said Waller.

Although the patent on valsartan (Diovan, Novartis) expired last Friday, a generic version of the popular antihypertensive drug has yet to make it to market. By contrast, a generic version of ...

Their drug, Diovan, has been determined not to be contaminated. Other companies also create drugs using generic Valsartan that never produced contaminated products.

The U.S. Food and Drug Administration has approved a new generic of the blood pressure medication valsartan to help alleviate a recent shortage due to multiple safety recalls.. Since last summer ...

Fallout from the Diovan case in Japan suggests that clinical drug studies on patients should be financed either with public research funds or through formal funding contracts between ...

For 2014, the company is projecting earnings growth in the low to mid-single digits, but that could end up better, Jimenez said, depending on when a generic of its blockbuster blood pressure drug ...

EAST HANOVER, N.J., Dec. 3 /PRNewswire/ -- Diovan(R) (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the U.S. Food and Drug Administration (FDA) ...

NEW DELHI—Ranbaxy Laboratories Ltd. won approval Thursday to produce a generic version of Novartis AG's blockbuster, blood-pressure drug Diovan, improving the Indian company's prospects after ...

drug shortage Alkem Laboratories Diovan valsartan. A few years ago India’s Alkem Laboratories was in the hot seat with the FDA, having had several plants cited by inspectors.

BASEL -- Swiss drug-maker Novartis AG Wednesday said its best-selling drug, the high-blood-pressure treatment Diovan, was well on track to soon achieve annual sales of $4 billion. At a ...

The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...

The Food and Drug Administration (FDA) has expanded the approval of Diovan (valsartan) to include patients 1 to 5 years of age for the treatment of hypertension. Previously, the treatment was ...